1477079
doi
10.5281/zenodo.1477079
oai:zenodo.org:1477079
user-sgc-dls-i04-1-fs
user-sgc-opennotebook
user-openlabnotebooks
Yue, Wyatt, W
Structural Genomics Consortium, University of Oxford
Brennan, Paul
Structural Genomics Consortium, University of Oxford
HAO1 inhibitor development: Screening of follow-up compounds from fragment hits by fluorescence-based activity assay - part 1 of 2
Mackinnon, Sabrina
Structural Genomics Consortium, University of Oxford
info:eu-repo/semantics/openAccess
Creative Commons Attribution 4.0 International
https://creativecommons.org/licenses/by/4.0/legalcode
HAO1
Glycolate oxidase
Amplex Red
Activity assay
hyperoxaluria
<p>This is part of the Open Lab Notebook initiative. To read the associated post please click <a href="https://openlabnotebooks.org/screening-follow-up-compounds-from-active-site-and-gating-loop-hao1-fragment-hits/">here</a>.</p>
<p> </p>
Funding Acknowledgment: The SGC is a registered charity (number 1097737) that receives funds from AbbVie, Bayer Pharma AG, Boehringer Ingelheim, Canada Foundation for Innovation, Eshelman Institute for Innovation, Genome Canada through Ontario Genomics Institute [OGI-055], Innovative Medicines Initiative (EU/EFPIA) [ULTRA-DD grant no. 115766], Janssen, Merck KGaA, Darmstadt, Germany, MSD, Novartis Pharma AG, Ontario Ministry of Research, Innovation and Science (MRIS), Pfizer, São Paulo Research Foundation-FAPESP, Takeda, and Wellcome.
Zenodo
2018-11-02
info:eu-repo/semantics/report
1477078
user-sgc-dls-i04-1-fs
user-sgc-opennotebook
user-openlabnotebooks
1579540916.541064
1980243
md5:4f0880b3392b8841f648a1915b747f42
https://zenodo.org/records/1477079/files/HAO1 inhibitor development Screening of follow-up compounds from fragment hits by fluorescence-based activity assay - deposition 1 of 2.pdf
public
10.5281/zenodo.1477078
isVersionOf
doi